Azlocillin: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:


{{Drugbox
{{Drugbox
| verifiedrevid = 458972860
| verifiedrevid = 458972860
| IUPAC_name = (2''S'',5''R'',6''R'')-3,3-dimethyl-7-oxo-6-{[(2''R'')-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
| IUPAC_name = (2''S'',5''R'',6''R'')-3,3-dimethyl-7-oxo-6-{[(2''R'')-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
| image = Azlocillin skeletal.svg
| image = Azlocillin.png


<!--Clinical data-->
<!--Clinical data-->
Line 41: Line 40:
| StdInChIKey = JTWOMNBEOCYFNV-NFFDBFGFSA-N
| StdInChIKey = JTWOMNBEOCYFNV-NFFDBFGFSA-N
}}
}}
              __NOTOC__
{{SI}}
{{CMG}}
==Overview==


'''Azlocillin''' is an [[acyl]][[ampicillin]] [[antibiotic]] with an extended spectrum of activity and greater ''[[in vitro]]'' potency than the carboxy [[penicillin]]s.
'''Azlocillin''' is an [[acyl]][[ampicillin]] [[antibiotic]] with an extended spectrum of activity and greater ''[[in vitro]]'' potency than the carboxy [[penicillin]]s.
Line 52: Line 55:


==References==
==References==
{{reflist|30em}}
{{reflist|2}}


{{PenicillinAntiBiotics}}
{{PenicillinAntiBiotics}}


[[Category:Beta-lactam antibiotics]]
[[Category:Beta-lactam antibiotics]]
[[Category:Enantiopure drugs]]
[[Category:Drug]]
[[Category:Imidazolidinones]]
 
 
{{Antibiotic-stub}}

Latest revision as of 13:50, 13 April 2015

Azlocillin
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H23N5O6S
Molar mass461.491 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Azlocillin

Articles

Most recent articles on Azlocillin

Most cited articles on Azlocillin

Review articles on Azlocillin

Articles on Azlocillin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Azlocillin

Images of Azlocillin

Photos of Azlocillin

Podcasts & MP3s on Azlocillin

Videos on Azlocillin

Evidence Based Medicine

Cochrane Collaboration on Azlocillin

Bandolier on Azlocillin

TRIP on Azlocillin

Clinical Trials

Ongoing Trials on Azlocillin at Clinical Trials.gov

Trial results on Azlocillin

Clinical Trials on Azlocillin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Azlocillin

NICE Guidance on Azlocillin

NHS PRODIGY Guidance

FDA on Azlocillin

CDC on Azlocillin

Books

Books on Azlocillin

News

Azlocillin in the news

Be alerted to news on Azlocillin

News trends on Azlocillin

Commentary

Blogs on Azlocillin

Definitions

Definitions of Azlocillin

Patient Resources / Community

Patient resources on Azlocillin

Discussion groups on Azlocillin

Patient Handouts on Azlocillin

Directions to Hospitals Treating Azlocillin

Risk calculators and risk factors for Azlocillin

Healthcare Provider Resources

Symptoms of Azlocillin

Causes & Risk Factors for Azlocillin

Diagnostic studies for Azlocillin

Treatment of Azlocillin

Continuing Medical Education (CME)

CME Programs on Azlocillin

International

Azlocillin en Espanol

Azlocillin en Francais

Business

Azlocillin in the Marketplace

Patents on Azlocillin

Experimental / Informatics

List of terms related to Azlocillin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Azlocillin is an acylampicillin antibiotic with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin is similar to mezlocillin and piperacillin. It demonstrates antibacterial activity against a broad spectrum of bacteria, including Pseudomonas aeruginosa and, in contrast to most cephalosporins, exhibits activity against enterococci.

Spectrum of bacterial susceptibility

Azlocillin is considered a broad spectrum antibiotic and can be used against a number of Gram positive and Gram negative bacteria. The following represents MIC susceptibility data for a few medically significant organisms.[1]

  • Escherichia coli 1 μg/mL - 32 μg/mL
  • Haemophilus spp. 0.03 μg/mL - 2 μg/mL
  • Pseudomonas aeruginosa 4 μg/mL - 6.25 μg/mL

References